Title |
Minority Based Community Clinical Oncology Program
|
Institution |
UNIVERSITY OF ILLINOIS AT CHICAGO, CHICAGO, IL
|
Principal Investigator |
PEACE, DAVID
|
NCI Program Director |
Worta McCaskill-Stevens
|
Cancer Activity |
Community Oncology and Rehabilitation
|
Division |
DCP
|
Funded Amount |
$936,500
|
Project Dates |
08/15/1997 - 05/31/2012
|
Fiscal Year |
2008
|
Project Type |
Grant
|
Research Topics w/ Percent Relevance |
Cancer Types w/ Percent Relevance |
Aging (4.0%)
Behavioral and Social Science (50.0%)
Cancer (100.0%)
Cancer Survivorship (19.0%)
Chemoprevention (8.0%)
Chemotherapy (47.0%)
Childhood Cancers (14.0%)
Digestive Diseases (16.0%)
Gene Therapy (1.0%)
Gene Therapy Clinical Trials (1.0%)
Hematology (8.0%)
Monoclonal Antibodies (1.0%)
Surgery (5.0%)
Taxol (13.0%)
|
Breast Cancer (34.0%)
Cervical Cancer (8.0%)
Colon/Rectum (15.0%)
Esophagus (1.0%)
Hodgkins disease (2.0%)
Lung (9.0%)
Lymphoma (4.0%)
Melanoma (1.0%)
Multiple Myeloma (1.0%)
Non Hodgkins Lymphoma (2.0%)
Ovarian Cancer (2.0%)
Prostate (16.0%)
Skin (1.0%)
Uterine (1.0%)
Leukemia (6.0%)
|
Research Type |
Education and Communication
Resources and Infrastructure Related to Cancer Control, Survivorship, and Outcomes Research
|
Abstract |
DESCRIPTION (provided by applicant): 1. To maintain the successful retention of African-American men to the Selenium and Vitamin E Selenium and Vitamin E Cancer Prevention Trial (SELECT) and the successful recruitment and retention of African- American men to SELECT ancillary studies. 2. To provide access to state-of-the-art cancer treatment for minority individuals by increasing minority participation in cancer treatment protocols using proven recruitment and retention strategies: 3. To raise the level of cancer prevention and control (CaP/C) opportunities offered throughout the Chicago and Northwest Indiana region by partnering with two major NCI-funded programs [Center for Population Health and Health Disparities (CPHHD) and the Patient Navigator Research Program (PNRP)] and Ingalls Health System. The UIC MB-CCOP plans to leverage these partnerships to establish a structure and framework to overcome the barriers to recruitment and retention and provide access to CaP/C trials to minority communities in this entire region. 4. To increase the awareness, understanding, and involvement of health care providers, community leaders, and local organizations in UIC MB-CCOP activities. These aims will be achieved by an established minority clinical research headquarters within the UIC Section of Hematology/Oncology and utilizes several research bases: Cancer and Leukemia Group B (CALGB): Main Member since 1996 Southwest Oncology Group (SWOG): CCOP Expanded Access Pilot Program (1998) Eastern Cooperative Oncology Group (ECOG): Accepted July 15, 2005 (by NCI permission) Gynecologic Oncology Group (GOG) National Surgical Adjuvant Breast and Bowel Project (NSABP): STAR & P-4 The University of Michigan CCOP Research Base: CaP/C The University of Rochester CCOP Research Base: CaP/C |